1-181483787-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP2PP3BS2
The NM_001205293.3(CACNA1E):c.43G>A(p.Gly15Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,611,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000048 ( 0 hom. )
Consequence
CACNA1E
NM_001205293.3 missense
NM_001205293.3 missense
Scores
4
10
5
Clinical Significance
Conservation
PhyloP100: 9.21
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1E. . Gene score misZ 5.8125 (greater than the threshold 3.09). Trascript score misZ 6.7013 (greater than threshold 3.09). GenCC has associacion of gene with developmental and epileptic encephalopathy, developmental and epileptic encephalopathy, 69.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.754
BS2
High AC in GnomAdExome4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1E | NM_001205293.3 | c.43G>A | p.Gly15Ser | missense_variant | 1/48 | ENST00000367573.7 | NP_001192222.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1E | ENST00000367573.7 | c.43G>A | p.Gly15Ser | missense_variant | 1/48 | 1 | NM_001205293.3 | ENSP00000356545.2 | ||
CACNA1E | ENST00000360108.7 | c.43G>A | p.Gly15Ser | missense_variant | 1/47 | 5 | ENSP00000353222.3 | |||
CACNA1E | ENST00000367570.6 | c.43G>A | p.Gly15Ser | missense_variant | 1/47 | 1 | ENSP00000356542.1 | |||
CACNA1E | ENST00000621791.4 | c.43G>A | p.Gly15Ser | missense_variant | 1/46 | 1 | ENSP00000481619.1 | |||
CACNA1E | ENST00000524607.6 | c.478G>A | p.Gly160Ser | missense_variant | 3/12 | 5 | ENSP00000432038.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151568Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
151568
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460200Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726322
GnomAD4 exome
AF:
AC:
7
AN:
1460200
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
726322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151568Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 73980
GnomAD4 genome
AF:
AC:
2
AN:
151568
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
73980
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with CACNA1E-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with serine at codon 15 of the CACNA1E protein (p.Gly15Ser). The glycine residue is weakly conserved and there is a small physicochemical difference between glycine and serine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;.;.;T;T;.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;.;D;.;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;M;.;M;.;M;M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;.;D;D;.;.;.;.
REVEL
Uncertain
Sift
Benign
.;T;.;T;T;.;.;.;.
Sift4G
Benign
.;T;T;T;T;T;T;T;T
Polyphen
0.93
.;P;.;.;.;.;P;.;.
Vest4
0.34, 0.34, 0.52, 0.54, 0.42, 0.47, 0.52
MVP
MPC
2.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at